LUMITHERA
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease. The company is developing solutions to prevent vision loss and blindness, improve visual function, and stop or slow the progression of blinding diseases of the eye. They delivering photobiomodulation (PBM) treatment for ocular disorders and diseases. LumiThera also focused on treating patients affected by dry age-related macular degeneration. The company’s expertise is in the application of photobiomodulation (PBM), using non-invasive light-emitting diodes (LED) for acute and chronic ocular diseases and disorders. The company was founded in 2013 and is headquartered in Poulsbo, Washington, United States.
LUMITHERA
Social Links:
Industry:
Health Care Manufacturing Medical Medical Device
Founded:
2013-01-01
Address:
Poulsbo, Washington, United States
Country:
United States
Website Url:
http://www.lumithera.com
Total Employee:
11+
Status:
Active
Contact:
+44-2076601516
Total Funding:
35.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Apnimed
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-26 | MacuLogix | MacuLogix acquired by LumiThera | N/A |
| 2021-11-11 | Diopsys | Diopsys acquired by LumiThera | N/A |
Investors List
Serengeti Asset Management
Serengeti Asset Management investment in Debt Financing - LumiThera
Leste Clearway
Leste Clearway investment in Debt Financing - LumiThera
Celeste Management
Celeste Management investment in Series C - LumiThera
Nikon
Nikon investment in Series C - LumiThera
Keiretsu Capital
Keiretsu Capital investment in Series C - LumiThera
WaterStart Capital
WaterStart Capital investment in Series C - LumiThera
Nikon
Nikon investment in Series C - LumiThera
WaterStart Capital
WaterStart Capital investment in Series C - LumiThera
WaterStone Capital
WaterStone Capital investment in Series B - LumiThera
RPR Venture
RPR Venture investment in Series B - LumiThera
Official Site Inspections
http://www.lumithera.com Semrush global rank: 6.45 M Semrush visits lastest month: 1,000
- Host name: mail.thorlaser.com
- IP address: 45.33.126.214
- Location: Dallas United States
- Latitude: 32.7787
- Longitude: -96.8217
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75270
More informations about "LumiThera"
Home | LumiThera US
LumiThera is a medical device company harnessing the power of light to offer a comprehensive approach for detecting, treating, and monitoring retinal diseases, particularly dry age-related …See details»
About LumiThera | LumiThera US
LumiThera is committed to creating a brighter horizon for patients by developing treatment solutions to improve visual function, stop or slow the progression of debilitating eye diseases and prevent vision loss and blindness.See details»
LumiThera Obtains FDA Authorization of Valeda Treatment for Dry …
Nov 4, 2024 · SEATTLE– (BUSINESS WIRE)–LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the …See details»
LumiThera - Crunchbase Company Profile & Funding
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease. The company is developing solutions to prevent vision loss and …See details»
LumiThera, Inc. - LinkedIn
LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. LumiThera, Inc. | 1,531 followers on...See details»
FDA grants authorization to LumiThera's Valeda system for dry AMD
Nov 5, 2024 · Just over 11 months after submitting a De Novo request for its lead product, LumiThera Inc. announced the FDA has authorized marketing of the Valeda Light Delivery …See details»
LumiThera Company Profile 2024: Valuation, Funding …
Developer of medical devices intended to prevent vision loss and blindness.See details»
FDA Approves LumiThera’s Valeda for Dry AMD Treatment | OBN
Nov 5, 2024 · The U.S. FDA has granted LumiThera authorization to market its Valeda Light Delivery System, the first FDA-authorized device designed to treat vision loss in patients with …See details»
LumiThera Company Profile - Office Locations, Competitors ... - Craft
LumiThera is a medical devices company that focuses on the development of photobiomodulation (PBM) treatments. It offers Valeda, a light delivery system for the treatment of dry age-related …See details»
LumiThera, Inc. Announces Creation of a Light-based ... - Newswire
Nov 11, 2021 · LumiThera is a commercial-stage medical device company focused on treating people affected by ocular damage and disease including dry age-related macular …See details»
Valeda | LumiThera US
The Valeda Light Delivery System is intended to provide improved visual acuity in patients with best corrected visual acuity of 20/32 through 20/70 and who have dry age-related macular …See details»
LumiThera’s Valeda Light Delivery System receives marketing ...
Nov 6, 2024 · LumiThera Inc. announced the US Food & Drug Administration (FDA) has authorized marketing of Valeda Light Delivery System for the treatment of patients with dry …See details»
FDA Clears its First Treatment for Dry AMD, with LumiThera's Light ...
Nov 19, 2024 · LumiThera, a Poulsbo-based medical device company specializing in ocular disease treatments, has received FDA clearance for the first-ever light-based therapy for dry …See details»
LumiThera Announces US LIGHTSITE III Clinical Trial Meets Primary ...
SEATTLE, March 22, 2022 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today …See details»
LumiThera, Inc. Announces Creation of a Light-based Theranostic ...
SEATTLE, Nov. 11, 2021 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today …See details»
LumiThera Announces Sustained Vision Improvement for 24 …
Mar 15, 2023 · LumiThera, Inc. is a medical device company focused on diagnosing, treating, and monitoring ocular disease and damage including dry age-related macular degeneration (AMD), …See details»
Valeda Light Delivery System Receives 2019 Medical Design
SEATTLE, June 12, 2019 /PRNewswire/ — LumiThera, Inc. and Product Creation Studio today announced that LumiThera’s Valeda Light Delivery System has been honored with a silver …See details»
LumiThera Obtains FDA Authorization of Valeda Treatment for Dry …
Nov 4, 2024 · SEATTLE–(BUSINESS WIRE)–LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the …See details»
LumiThera Announces Sustained Vision Improvement for 24 …
Mar 15, 2023 · LumiThera, Inc. is a medical device company focused on diagnosing, treating, and monitoring ocular disease and damage including dry age-related macular degeneration (AMD), …See details»
LumiThera, Inc. Announces Creation of a Light-based Theranostic ...
SEATTLE, Nov. 11, 2021 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today …See details»